bioAffinity Technologies, Inc.
USD0.82
+0.02 (+2.40%)
CEO
Maria Zannes
IPO Date
2022-09-01
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$0.80
Prev. Close
$0.80
Day Low
$0.80
Day High
$0.83
52W Low
$0.69
52W High
$13.50
Market Cap
$0.00B
Volume
0.16M
| -1.2 |
| 31 Dec 2023 | FY | 31.3% | -313.5% | -163.5% | -96.5% | 0.33 | 1.77 | -1.6 |
| 31 Dec 2022 | FY | 90.3% | -169771.2% | -73.8% | -66.9% | 0.02 | 10.50 | -0.9 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 40.1% | -435.3% | -0.72 | 0.11 | -3.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 48.2% | -4992.1% | -0.66 | 0.01 | -8.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 82.0% | -502.0% | -0.99 | 0.13 | -18.5 |
| -0.2 |
| 30 Sept 2025 | Q3 | 27.0% | -349.3% | -56.7% | -43.7% | 0.08 | 3.65 | -0.2 |
| 30 Jun 2025 | Q2 | 19.9% | -319.9% | 190.1% | -85.5% | -0.31 | 0.64 | -0.4 |
| 31 Mar 2025 | Q1 | 26.2% | -143.5% | -184.8% | -48.0% | 0.92 | 0.55 | -0.4 |
| 31 Dec 2024 | Q4 | 22.3% | -134.4% | -114.0% | -45.5% | 0.58 | 0.87 | -1.0 |
| 30 Sept 2024 | Q3 | 38.7% | -85.1% | -64.1% | -30.5% | 0.55 | 1.02 | -3.2 |
| 30 Jun 2024 | Q2 | 41.3% | -88.0% | -61.5% | -31.7% | 0.54 | 1.15 | -3.0 |
| 31 Mar 2024 | Q1 | 34.6% | -81.5% | -37.3% | -24.4% | 0.28 | 2.22 | -2.6 |
| 31 Dec 2023 | Q4 | 18.1% | -107.2% | -48.9% | -28.9% | 0.33 | 1.77 | -1.4 |